Clinical Trial

Photobiomodulation on Core Symptoms of Autism

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 21, 2026 (before its estimated July 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the effectiveness of photobiomodulation therapy on core symptoms in children with autism spectrum disorder. Participants will receive designed physical therapy, occupational therapy and speech program in addition to Photobiomodulation over a defined period. Out comes will be assessed using standardized clinical scales to determine improvements in social interactions, communication and behavior.
Trial Details
NCT Number NCT07542899
Lead Sponsor Suez University
Conditions Autism
Enrollment 30 participants
Start Date 2026-04-10
Primary Completion 2026-07-10 (estimated)
Study Completion 2026-08-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-21